ATAI Life Sciences N.V.
ATAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.72B
Close$
$0.01
99.9% downside
Current Fair Value
99.9% downsideOvervalued by 99.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.72 Billion |
|---|---|
| Enterprise Value | $2.55 Billion |
| Dividend Yield | $6.75 (91.84%) |
| Earnings per Share | $-2.91 |
| Beta | 1.55 |
| Outstanding Shares | 360,753,298 |
Return
| Return on Equity | -378.87% |
|---|---|
| Return on Assets | -252.35% |
| Return on Invested Capital | -60.29% |
Valuation & Multiples
| P/E Ratio | -2.53 |
|---|---|
| PEG | -14.66 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 571.12 |
| Enterprise Value to EBIT | -17.93 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$111,111
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$266,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2823▲ 3.94% |
|---|---|
| Total Calls | 2,005,800▲ 78.71% |
| Total Puts | 566,300▲ 107.66% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.75%▲ 9.68% |
|---|---|
| Total Invested | $717.20M▲ 99.35% |
| Investors Holding | 249▲ 55.00% |
ESG Score
No data
About ATAI Life Sciences N.V.
35 employees